Literature DB >> 20537406

Effect of anxiety on treatment presentation and outcome: results from the Marijuana Treatment Project.

Julia D Buckner1, Kathleen M Carroll.   

Abstract

Despite emerging evidence of the efficacy of psychotherapies for marijuana dependence, variability in outcome exists. This study examined the role of anxiety on treatment involvement and outcome. Four questions were examined: (1) Is greater anxiety associated with greater impairment at baseline? (2) Is baseline anxiety related to greater marijuana use and problems following treatment? (3) Does adding cognitive-behavioral therapy (CBT) to motivation enhancement therapy (MET) reduce anxiety relative to MET alone; (4) Are reductions in anxiety associated with better outcomes? The sample comprised 450 marijuana-dependent patients in the Marijuana Treatment Project. Marijuana use and anxiety were measured at pretreatment and 4- and 9-month follow-ups. At baseline, anxiety was linked to more marijuana-related problems. CBT was associated with less anxiety at follow-up compared to MET alone. Reductions in anxiety were related to less marijuana use. In fact, reduction in anxiety from baseline to 4-month follow-up was associated with less marijuana use at 9 months, but reduction in marijuana use did not predict subsequent anxiety. Data suggest that anxiety is an important variable that deserves further attention in marijuana-dependence treatment. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20537406      PMCID: PMC2914117          DOI: 10.1016/j.psychres.2009.10.010

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  39 in total

1.  Brief treatments for cannabis dependence: findings from a randomized multisite trial.

Authors: 
Journal:  J Consult Clin Psychol       Date:  2004-06

2.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

3.  Peer influence and gender differences in problematic cannabis use among individuals with social anxiety.

Authors:  Julia D Buckner; Michael A Mallott; Norman B Schmidt; Jeanette Taylor
Journal:  J Anxiety Disord       Date:  2006-04-18

4.  Relations between anxiety sensitivity, distress tolerance, and fear reactivity to bodily sensations to coping and conformity marijuana use motives among young adult marijuana users.

Authors:  Michael J Zvolensky; Erin C Marshall; Kirsten Johnson; Julianna Hogan; Amit Bernstein; Marcel O Bonn-Miller
Journal:  Exp Clin Psychopharmacol       Date:  2009-02       Impact factor: 3.157

5.  The effect of imaginal exposure length on outcome of treatment for PTSD.

Authors:  Agnes van Minnen; Edna B Foa
Journal:  J Trauma Stress       Date:  2006-08

6.  Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence.

Authors:  Julia D Buckner; Norman B Schmidt; Alan R Lang; Jason W Small; Robert C Schlauch; Peter M Lewinsohn
Journal:  J Psychiatr Res       Date:  2007-02-23       Impact factor: 4.791

7.  Treating Comorbid Social Anxiety and Alcohol Use Disorders: Combining Motivation Enhancement Therapy With Cognitive-Behavioral Therapy.

Authors:  Julia D Buckner; Deborah Roth Ledley; Richard G Heimberg; Norman B Schmidt
Journal:  Clin Case Stud       Date:  2008-06

Review 8.  Self-medication in social phobia: a review of the alcohol literature.

Authors:  Maureen H Carrigan; Carrie L Randall
Journal:  Addict Behav       Date:  2003-03       Impact factor: 3.913

9.  Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes.

Authors: 
Journal:  Alcohol Clin Exp Res       Date:  1998-09       Impact factor: 3.455

10.  A randomized pilot study of motivation enhancement therapy to increase utilization of cognitive-behavioral therapy for social anxiety.

Authors:  Julia D Buckner; Norman B Schmidt
Journal:  Behav Res Ther       Date:  2009-05-07
View more
  22 in total

1.  The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC).

Authors:  Julia D Buckner; Richard G Heimberg; Franklin R Schneier; Shang-Min Liu; Shuai Wang; Carlos Blanco
Journal:  Drug Alcohol Depend       Date:  2012-01-21       Impact factor: 4.492

2.  Dimensions and severity of marijuana consequences: development and validation of the Marijuana Consequences Questionnaire (MACQ).

Authors:  Jeffrey S Simons; Robert D Dvorak; Jennifer E Merrill; Jennifer P Read
Journal:  Addict Behav       Date:  2012-01-14       Impact factor: 3.913

3.  Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study.

Authors:  Brian J Sherman; Aimee L McRae-Clark; Nathaniel L Baker; Susan C Sonne; Therese K Killeen; Kasie Cloud; Kevin M Gray
Journal:  Am J Addict       Date:  2017-02-02

4.  Immediate antecedents of marijuana use: an analysis from ecological momentary assessment.

Authors:  Julia D Buckner; Ross D Crosby; Jose Silgado; Stephen A Wonderlich; Norman B Schmidt
Journal:  J Behav Ther Exp Psychiatry       Date:  2011-09-14

5.  Emotion regulation and coping motives serially affect cannabis cessation problems among dually diagnosed outpatients.

Authors:  Julia D Buckner; Katherine A Walukevich; Michael J Zvolensky; Matthew W Gallagher
Journal:  Psychol Addict Behav       Date:  2017-08-28

6.  Cannabis use behaviors and social anxiety: the roles of perceived descriptive and injunctive social norms.

Authors:  Anthony H Ecker; Julia D Buckner
Journal:  J Stud Alcohol Drugs       Date:  2014-01       Impact factor: 2.582

7.  Anxiety and cannabis-related problem severity among dually diagnosed outpatients: The impact of false safety behaviors.

Authors:  Julia D Buckner; Michael J Zvolensky; Anthony H Ecker; Emily R Jeffries; Austin W Lemke; Kimberlye E Dean; Michael S Businelle; Matthew W Gallagher
Journal:  Addict Behav       Date:  2017-02-10       Impact factor: 3.913

8.  Integrated cognitive behavioral therapy for comorbid cannabis use and anxiety disorders: A pilot randomized controlled trial.

Authors:  Julia D Buckner; Michael J Zvolensky; Anthony H Ecker; Norman B Schmidt; Elizabeth M Lewis; Daniel J Paulus; Paula Lopez-Gamundi; Kathleen A Crapanzano; Jafar Bakhshaie
Journal:  Behav Res Ther       Date:  2018-10-26

9.  Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.

Authors:  Aimee L McRae-Clark; Nathaniel L Baker; Kevin M Gray; Therese K Killeen; Amanda M Wagner; Kathleen T Brady; C Lindsay DeVane; Jessica Norton
Journal:  Drug Alcohol Depend       Date:  2015-08-25       Impact factor: 4.492

10.  Integrated cognitive behavioral therapy for cannabis use and anxiety disorders: rationale and development.

Authors:  Julia D Buckner; Michael J Zvolensky; Norman B Schmidt; Kathleen M Carroll; Chris Schatschneider; Kathleen Crapanzano
Journal:  Addict Behav       Date:  2013-10-29       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.